Health
Pharmalittle Drug Concerns Rise
Patient advocates and experts are raising concerns over a rare disease drug from Neurocrine Biosciences, citing potential risks. The company faces scrutiny amid growing alarm about the medication’s safety.
Coverage timeline — 1 article
STAT News
Patient advocates and some experts are expressing growing alarm over the perceived risks of a Neurocrine Biosciences rare disease drug
2026-10-13 13:29 UTC